2030 年图像引导放射治疗市场报告(按细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPRE00009118
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Image Guided Radiotherapy Market Forecast Report | Size, Share & Growth Drivers 2030

Buy Now

【研究报告】影像引导放疗市场规模预计将从2022年的18.1425亿美元激增至2030年的56.5072亿美元;预计 2022 年至 2030 年该市场将以 15.3% 的复合年增长率增长。
分析师观点:
在尖端技术进步和技术的推动下,图像引导放射治疗市场将见证显着的增长和转型。个性化癌症治疗的重要性日益增加。图像引导放射治疗通过实时成像精确定位肿瘤,在最大限度地减少健康组织的辐射暴露方面发挥着关键作用,从而减少副作用并改善患者的治疗效果。通过将人工智能 (AI) 和机器学习 (ML) 算法结合在一起,图像引导放射治疗系统变得更加复杂,使肿瘤学家能够以前所未有的准确性根据个体患者的需求定制放射治疗计划。此外,图像引导放射治疗的可及性和可负担性预计将增加,确保更多患者能够从这种革命性的癌症治疗方法中受益,最终提高癌症患者的生存率并改善生活质量。< br>市场概况:
放射治疗是一种用电离辐射治疗癌细胞的局部治疗方法。图像引导放射治疗是在放射治疗过程中利用周期性二维和三维成像,根据实际放射治疗计划的图像坐标来指导放射治疗的方法。图像引导放射治疗可以帮助减少手术的侵入性和精确性,从而缩短住院时间并减少手术次数。图像引导放射治疗是追踪癌症并保护正常组织的最先进技术。该技术是最有效的放射治疗类型之一,可减少正常组织的放射剂量,减少副作用并改善治疗结果。
图像引导放射治疗市场的增长是由协同因素推动的,包括强大的医疗基础设施、不断增加的癌症患病率、有利的报销政策、技术创新、积极的研究举措、明确的监管框架以及微创手术的不断采用。持续的技术进步、对非侵入性癌症干预措施的更加重视以及支持性的医疗保健生态系统预计将维持这一上升趋势。

市场驱动因素:
全球癌症患病率上升推动全球影像引导放射治疗市场
全球卫生系统的癌症患病率正在大幅增加。根据世界卫生组织 (WHO) 的数据,2019 年全球约有 960 万人死于癌症。根据同一来源,结直肠癌、肝癌、前列腺癌、肺癌和胃癌在男性中最常见,而乳腺癌、结直肠癌和宫颈癌在女性中最常见。
根据英国癌症研究中心,2020 年,英国每年约有 16 万人死于癌症。据世界卫生组织称,癌症是全球死亡的主要原因之一,到 2020 年将导致约 1000 万人死亡。 2020 年最常见的癌症是乳腺癌(226 万例)和肺癌(221 万例)。据美国癌症协会预测,到 2040 年,全球癌症负担预计将达到约 2840 万例,较 2020 年增加 47%,其中由于人口变化,发展中国家的增加幅度更大。然而,全球化和经济增长可能加剧风险因素的增加,从而进一步加剧这种情况。全球癌症观察站(GLOBOCAN)估计,2020年全球有1930万癌症病例。GLOBOCAN预测,2040年印度癌症病例将比2020年上升至208万,增长57.5%。据世界卫生组织称,全球有近 230 万女性被检测出患有乳腺癌,2020 年约有 685,000 人因此死亡。据 Advocate Health Care 称,超过 60% 的癌症患者接受某种形式的放射治疗,作为其治疗的一部分。治疗。这是因为放射疗法在对抗多种类型的癌症方面非常有效,因为它会破坏癌细胞的繁殖能力。图像引导放射治疗使放射治疗师能够更好地定位目标区域,并在治疗前甚至治疗期间将放射束引导至肿瘤。因此,癌症的高患病率预计将推动影像引导放射治疗的采用。
根据世界卫生组织 2021 年 3 月发布的数据,超过 50% 的癌症患者将放射治疗作为癌症管理和护理的一部分。此外,根据相同的数据,放射疗法主要用于治疗最常见的癌症类型,例如结直肠癌、肺癌、乳腺癌和宫颈癌。从患者的角度来看,早期发现和诊断可以避免不必要的痛苦和痛苦。它还可以减少治疗规模和成本。此外,政府意识将推动市场。例如,英国公共卫生局与英国卫生部和英国国民医疗服务体系 (NHS England) 合作,领导了“明确癌症”计划。该计划旨在通过提高公众对癌症体征和症状的认识,并进一步敦促人们立即去看医生,来改善癌症的早期诊断。
细分分析:
根据类型,图像引导放射治疗市场是细分为产品和服务。产品领域在 2022 年占据最大的市场份额。服务领域预计在 2022 年至 2030 年期间复合年增长率最高,达到 15.5%。人们对放射治疗的认识不断提高,从而增加了对直线加速器 (LINAC) 和 MRI-LINAC 等放射治疗设备的需求,这些设备有助于向大量患者提供治疗。此外,肿瘤中心的巨大增长进一步产生了对放射治疗设备的需求,从而推动了产品领域并促进了图像引导放射治疗市场的增长。
根据应用,图像引导放射治疗市场细分为乳腺癌、肺癌、胃肠癌、前列腺癌、妇科癌症、头颈癌等。乳腺癌细分市场在 2022 年占据最大的市场份额。预计肺癌细分市场在 2022 年至 2030 年期间复合年增长率最高,达到 16.3%。
根据成像类型,图像引导放射治疗市场细分为磁共振成像(MRI)、正电子发射断层扫描 (PET)、计算机断层扫描 (CT) 成像等。磁共振成像 (MRI) 细分市场在 2022 年占据最大的市场份额。计算机断层扫描 (CT) 成像细分市场预计 2022 年至 2030 年复合年增长率最高,达到 15.8%。
基于最终用户,图像引导放射治疗市场分为医院、肿瘤中心和放射治疗中心。医院细分市场在 2022 年占据最大的市场份额。肿瘤中心细分市场预计在 2022 年至 2030 年期间复合年增长率最高,达到 16.0%。
区域分析:
北美在图像引导放射治疗市场占据主导地位。 2022年北美影像引导放疗市场价值为7.607亿美元,预计到2030年将达到24.0912亿美元;预计 2022 年至 2030 年复合年增长率为 15.5%。北美图像引导放射治疗市场分为美国、加拿大和墨西哥。北美拥有先进的医疗基础设施,这是由于癌症发病率较高。在北美,先进的医疗基础设施加上容易获得最先进的医疗技术,为整合先进的治疗方式(例如图像引导放射治疗)创造了有利的环境。该地区特别全面的医疗报销框架正在增加复杂治疗的采用,包括图像引导放射治疗,确保更多患者能够获得这些治疗。这些因素的结合支撑了扩大和加强影像引导放射治疗市场的动力。
由于先进的治疗设施、合格的医疗专业人员、以及政府对研究和开发的支持。由于癌症患病率不断上升、癌症意识不断增强以及新疗法的出现,亚太地区成为增长最快的市场。
主要参与者分析:
ViewRay、GE Healthcare、Hitachi, Ltd.;西门子股份公司、皇家飞利浦 NV;东芝公司、瓦里安医疗系统公司;视觉RT有限公司; Elekta AB、Accuray Incorporated 和 HORIBA Group 是图像引导放射治疗市场研究中分析的主要参与者之一。
最新动态:
在图像引导放射治疗市场运营的公司高度采用合并等无机和有机策略和收购。下面列出了近期的一些市场动态:
2023 年 5 月,飞利浦通过 Zenition 10 扩展了其移动 C 臂产品组合。2023 年 4 月,GE HealthCare 通过 Zenition 10 扩展了其磁共振成像 (MRI) 造影剂产品组合推出 Pixxoscan。它为客户提供了两种领先的大环分子:Clariscan(钆特酸)和 Pixxoscan(钆布醇)。 2023 年 6 月,GE HealthCare 宣布计划利用 AIR 技术扩展其 PET/MR 能力,以提高诊断精度并简化治疗评估,同时提高患者舒适度。2022年9月,中国监管机构国家药品监督管理局(NMPA)批准销售和使用ViewRay的MRIdian MRI引导放射治疗系统。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the image guided radiotherapy market?

The factors driving the growth of the image guided radiotherapy market include the rising prevalence of cancer worldwide and the introduction of technologically advanced systems.

Who are the major players in the image guided radiotherapy market?

The image guided radiotherapy market majorly consists of the players such as ViewRay, GE Healthcare, Hitachi, Ltd.; Siemens AG, Koninklijke Philips N.V.; TOSHIBA CORPORATION, Varian Medical Systems, Inc.; Vision RT Ltd.; Elekta AB, Accuray Incorporated, and HORIBA Group.

What is image guided radiotherapy?

Radiation therapy is a local treatment used to treat cancer cells with ionizing radiation. Image-guided radiation therapy is the method of using periodic two- and three-dimensional imaging during radiation treatment to guide radiation therapy based on the image coordinates of the actual radiation treatment plan. Image-guided radiation therapy can help make surgeries less invasive and precise, resulting in shorter hospital stays and fewer procedures. Image-guided radiation therapy is the most advanced technology for tracking cancer and sparing normal tissue. The technology is one of the most efficient types of radiation therapy, reducing the radiation dose to normal tissue, reducing side effects, and improving outcomes.

Which segment is dominating the image guided radiotherapy market?

The global image guided radiotherapy market, based on therapy type is segmented product and services. The product segment held the largest market share in 2022. The proton beam therapy segment is anticipated to register the highest CAGR of 15.5% during 2022–2030. Based on application, the image guided radiotherapy market is segmented into breast cancer, lung cancer, gastrointestinal cancer, prostate cancer, gynecological cancers, head and neck cancer, and others. The breast cancer segment held the largest market share in 2022. The lung cancer segment is anticipated to register the highest CAGR of 16.3% during 2022–2030. Based on imaging type, the image guided radiotherapy market is segmented into magnetic resonance imaging (MRI), positron emission tomography (PET), computed tomography (CT) imaging, and others. The magnetic resonance imaging (MRI) segment held the largest market share in 2022. The computed tomography (CT) imaging segment is anticipated to register the highest CAGR of 15.8% from 2022 to 2030. The image guided radiotherapy market, based on end user is segmented into hospitals, oncology centers, and radiotherapy centers. The hospitals segment held the largest market share in 2022. The oncology centers segment is anticipated to register the highest CAGR of 16.0% during 2022–2030.

What are the growth estimates for the image guided radiotherapy market till 2030?

The image guided radiotherapy market is expected to be valued at US$ 5,650.72million in 2030.

What was the estimated image guided radiotherapy market size in 2022?

The image guided radiotherapy market was valued at US$ 1,814.25 million in 2022.

The List of Companies - Image Guided Radiotherapy Market

  1. ViewRay
  2. GE Healthcare
  3. Hitachi, Ltd.
  4. Siemens AG
  5. Koninklijke Philips N.V.
  6. TOSHIBA CORPORATION
  7. Varian Medical Systems, Inc.
  8. Vision RT Ltd.
  9. Elekta AB
  10. Accuray Incorporated
  11. HORIBA Group

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..